Dendritic cells from the elderly display an intrinsic defect in the production of IL-10 in response to Lithium Chloride

Experimental Gerontology

Volumn 48, Issue 11, 2013, Pages 1285-1292

  Agrawal, Sudhanshu ^a   Gollapudi, Sastry ^a   Gupta, Sudhir ^a   Agrawal, Anshu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Dendritic cells; Human; Lithium Chloride; TLR2; TLR4

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 5; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LITHIUM CHLORIDE; TOLL LIKE RECEPTOR 2 AGONIST; TOLL LIKE RECEPTOR 4 AGONIST; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL AGING; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DENDRITIC CELL; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; POLARIZATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL;

AGING; DENDRITIC CELLS; HUMAN; LITHIUM CHLORIDE; TLR2; TLR4;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIGENS, CD80; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LIPOPROTEINS; LITHIUM CHLORIDE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84884154793     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2013.08.006     Document Type: Article

References (36)

1. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van Dyke T., Pulendran B. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol. 2003, 171:4984-4989.
2. Agrawal A., Agrawal S., Cao J.N., Su H., Osann K., Gupta S. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J. Immunol. 2007, 178:6912-6922.
3. Agrawal A., Kaushal P., Agrawal S., Gollapudi S., Gupta S. Thimerosal induces TH2 responses via influencing cytokine secretion by human dendritic cells. J. Leukoc. Biol. 2007, 81:474-482.
4. Agrawal A., Tay J., Ton S., Agrawal S., Gupta S. Increased reactivity of dendritic cells from aged subjects to self antigen, the human DNA. J. Immunol. 2009, 182:1138-1145.
5. Agrawal S., Gupta S., Agrawal A. Human dendritic cells activated via dectin-1 are efficient at priming Th17, cytotoxic CD8 T and B cell responses. PLoS One 2010, 5:e13418.
6. Beurel E., Michalek S.M., Jope R.S. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol. 2010, 31:24-31.
7. Boren E., Gershwin M.E. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun. Rev. 2004, 3:401-406.
8. Braat H., Rottiers P., Hommes D.W., Huyghebaert N., Remaut E., Remon J.P., van Deventer S.J., Neirynck S., Peppelenbosch M.P., Steidler L. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin. Gastroenterol. Hepatol. 2006, 4:754-759.
9. Brown J., Wang H., Hajishengallis G.N., Martin M. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J. Dent. Res. 2011, 90:417-427.
10. Chung H.Y., Cesari M., Anton S., Marzetti E., Giovannini S., Seo A.Y., Carter C., Yu B.P., Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009, 8:18-30.
11. Ciaramella A., Spalletta G., Bizzoni F., Salani F., Caltagirone C., Bossu P. Effect of age on surface molecules and cytokine expression in human dendritic cells. Cell. Immunol. 2011, 269:82-89.
12. Coant N., Simon-Rudler M., Gustot T., Fasseu M., Gandoura S., Ragot K., Abdel-Razek W., Thabut D., Letteron P., Ogier-Denis E., Ouziel R., Deviere J., Lizard G., Tellier Z., Lebrec D., Moreau R. Glycogen synthase kinase 3 involvement in the excessive proinflammatory response to LPS in patients with decompensated cirrhosis. J. Hepatol. 2011, 55:784-793.
13. Coombes J.L., Robinson N.J., Maloy K.J., Uhlig H.H., Powrie F. Regulatory T cells and intestinal homeostasis. Immunol. Rev. 2005, 204:184-194.
14. Cortes-Vieyra R., Bravo-Patino A., Valdez-Alarcon J.J., Juarez M.C., Finlay B.B., Baizabal-Aguirre V.M. Role of glycogen synthase kinase-3 beta in the inflammatory response caused by bacterial pathogens. J. Inflamm. (Lond) 2012, 9:23.
15. Dorshkind K., Swain S. Age-associated declines in immune system development and function: causes, consequences, and reversal. Curr. Opin. Immunol. 2009, 21:404-407.
16. Freland L., Beaulieu J.M. Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front. Mol. Neurosci. 2012, 5:14.
17. Hofmann C., Dunger N., Scholmerich J., Falk W., Obermeier F. Glycogen synthase kinase 3-beta: a master regulator of toll-like receptor-mediated chronic intestinal inflammation. Inflamm. Bowel Dis. 2010, 16:1850-1858.
18. Hu X., Paik P.K., Chen J., Yarilina A., Kockeritz L., Lu T.T., Woodgett J.R., Ivashkiv L.B. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 2006, 24:563-574.
19. Iyer S.S., Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit. Rev. Immunol. 2012, 32:23-63.
20. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
21. Knijff E.M., Breunis M.N., Kupka R.W., de Wit H.J., Ruwhof C., Akkerhuis G.W., Nolen W.A., Drexhage H.A. An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disord. 2007, 9:743-753.
22. Liu K.J., Lee Y.L., Yang Y.Y., Shih N.Y., Ho C.C., Wu Y.C., Huang T.S., Huang M.C., Liu H.C., Shen W.W., Leu S.J. Modulation of the development of human monocyte-derived dendritic cells by lithium chloride. J. Cell. Physiol. 2011, 226:424-433.
23. Makoukji J., Belle M., Meffre D., Stassart R., Grenier J., Shackleford G., Fledrich R., Fonte C., Branchu J., Goulard M., de Waele C., Charbonnier F., Sereda M.W., Baulieu E.E., Schumacher M., Bernard S., Massaad C. Lithium enhances remyelination of peripheral nerves. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:3973-3978.
24. Manicassamy S., Pulendran B. Modulation of adaptive immunity with Toll-like receptors. Semin. Immunol. 2009, 21:185-193.
25. Martin M., Rehani K., Jope R.S., Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 2005, 6:777-784.
26. McElhaney J.E., Effros R.B. Immunosenescence: what does it mean to health outcomes in older adults?. Curr. Opin. Immunol. 2009, 21:418-424.
27. Montero-Lomeli M., Galvao D., Morais B.B., Nardi A.E. Erythrocyte phosphoglucomutase activity of bipolar I patients currently using lithium or carbamazepine. Braz J Med Biol Res. 2007, 40:19-25.
28. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
29. Murray P.J., Smale S.T. Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat. Immunol. 2012, 13:916-924.
30. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
31. Spinnler K., Mezger M., Steffens M., Sennefelder H., Kurzai O., Einsele H., Loeffler J. Role of glycogen synthase kinase 3 (GSK-3) in innate immune response of human immature dendritic cells to Aspergillus fumigatus. Med Mycol. 2010, 48:589-597.
32. Wang H., Brown J., Martin M. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response. Cytokine 2011, 53:130-140.
33. Weiskopf D., Weinberger B., Grubeck-Loebenstein B. The aging of the immune system. Transpl. Int. 2009, 22:1041-1050.
34. Woodgett J.R., Ohashi P.S. GSK3: an in-Toll-erant protein kinase?. Nat. Immunol. 2005, 6:751-752.
35. Zhang X., Heng X., Li T., Li L., Yang D., Du Y., Doody R.S., Le W. Long-term treatment with lithium alleviates memory deficits and reduces amyloid-beta production in an aged Alzheimer's disease transgenic mouse model. J. Alzheimers Dis. 2011, 24:739-749.
36. Zhu J., Yamane H., Paul W.E. Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 2010, 28:445-489.